Boxer Capital LLC 13D and 13G filings for Syndax Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2021-02-16 4:22 pm Sale |
2020-12-31 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Boxer Capital LLC | 2,358,005 4.990% |
-405,564 (-14.68%) |
Filing |
| 2020-05-11 5:16 pm Purchase |
2020-04-30 | 13G | Syndax Pharmaceuticals, Inc. SNDX |
Boxer Capital LLC | 2,763,569 7.600% |
2,763,569 (New Position) |
Filing |